# Haploidentical Stem Cell Transplant for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Ultrasound

> **NCT00152113** · PHASE1 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 5 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **PROCEDURE:** Hematopoietic Stem Cell Transplantation
- **DEVICE:** CliniMACS
- **DRUG:** See intervention description

## Key facts

- **NCT ID:** NCT00152113
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2008-12
- **Final completion:** 2009-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2017-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152113, "Haploidentical Stem Cell Transplant for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Ultrasound". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00152113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*